Research Insights
BIOTIDE UK · RESEARCH LIBRARY

What Is Semax? A Peptide Research Overview

Explore Semax from a scientific research perspective, including its peptide structure, ACTH-derived sequence, areas of experimental interest and laboratory research considerations.
13 September 2026
7 min read
Research focused
Research use only

BioTide UK materials are supplied strictly for laboratory, analytical and scientific research purposes. They are not intended for human consumption or therapeutic use.

Semax is a synthetic peptide that has attracted scientific interest within experimental research involving neuronal signalling, peptide biology and molecular pathways associated with the nervous system.

Its structure is derived from a fragment associated with adrenocorticotropic hormone (ACTH), although Semax itself should be treated as a distinct research peptide rather than as ACTH.

This guide explores what Semax is, its relationship to ACTH-derived peptide research, the scientific areas in which it has been investigated and what researchers should consider when evaluating Semax research materials.

What is Semax?

Semax is a synthetic heptapeptide, meaning its structure contains seven amino-acid residues.

Its sequence is commonly represented as:

Met-Glu-His-Phe-Pro-Gly-Pro

The first portion of this sequence is related to a fragment of ACTH, while additional residues form the complete Semax sequence.

Research context

BioTide UK Semax is supplied exclusively for legitimate laboratory, scientific and analytical research. Discussion of experimental neurological or molecular pathways does not represent an intended therapeutic use.

How many amino acids are in Semax?

Semax contains seven amino-acid residues, making it a heptapeptide.

Peptide length and sequence are important because the precise arrangement of amino acids contributes to molecular identity and experimental behaviour.

Researchers should therefore distinguish Semax from related peptide fragments even when they share portions of the same sequence.

How is Semax related to ACTH?

Semax was developed from research involving a fragment associated with adrenocorticotropic hormone.

ACTH is a substantially larger peptide hormone with its own biological functions and molecular identity.

Semax incorporates an ACTH-related sequence within a distinct seven-residue peptide structure.

This means Semax and ACTH should not be treated as interchangeable compounds.

Semax vs ACTH

Characteristic Semax ACTH
Classification Synthetic heptapeptide Peptide hormone
Length 7 amino acids 39 amino acids
Structurally related? Contains an ACTH-related fragment Parent hormone sequence
Same compound? No No

Why is Semax researched?

Semax has appeared in experimental literature involving several areas of molecular and nervous-system research.

Scientific investigation has included areas such as:

  • Neuronal signalling
  • Neurotrophic-factor-related pathways
  • Gene-expression research
  • Cellular responses to experimental stress
  • Peptide signalling
  • Structure-activity relationships

These describe areas of experimental research rather than established therapeutic outcomes.

Semax and neuronal signalling research

Neurons communicate through complex networks involving receptors, neurotransmitters, peptides and intracellular signalling systems.

Researchers investigating Semax have examined changes within some of these molecular pathways under controlled experimental conditions.

The objective of such research is to understand how a particular peptide interacts with biological systems rather than to assume an outcome based solely on its molecular classification.

Semax and neurotrophic-factor research

Another area encountered within Semax literature involves neurotrophic factors.

Neurotrophic factors are signalling proteins involved in the development, maintenance and function of neuronal systems.

Experimental research has investigated relationships between Semax and molecular pathways associated with neurotrophic-factor signalling and expression.

Important distinction

Observing changes in a molecular signalling pathway does not by itself establish a therapeutic or cognitive outcome. Experimental findings must be interpreted within the conditions and limitations of each study.

Semax and gene-expression research

Gene expression describes the processes through which information encoded in DNA contributes to the production of functional molecules such as RNA and proteins.

Researchers can examine whether experimental conditions alter the expression of particular genes or groups of genes.

Semax has appeared in research examining changes in gene-expression patterns associated with neuronal and cellular signalling systems.

Why peptide sequence matters

A peptide's amino-acid sequence forms its primary molecular structure.

Even peptides derived from the same parent sequence can behave differently when residues are added, removed or substituted.

Researchers should therefore document the exact compound rather than assuming that an ACTH-derived peptide possesses all characteristics of the complete ACTH molecule.

Semax vs Selank

Semax and Selank are sometimes discussed together because both appear within experimental research involving nervous-system signalling. However, they are distinct peptide sequences.

Characteristic Semax Selank
Peptide length 7 amino acids 7 amino acids
Same sequence? No No
Same compound? No No
Research overlap Neuronal and peptide signalling research Neuronal and peptide signalling research

Researchers should evaluate evidence for each peptide independently rather than treating Semax and Selank as interchangeable.

For additional background on the second peptide, see our Selank research overview.

What should researchers look for when sourcing Semax?

1. Exact peptide identity

The material should be clearly identified as Semax and distinguished from related peptide sequences.

2. Supplied quantity

Researchers should record the amount of material associated with their experimental work.

3. Batch identification

A batch or lot identifier helps connect the physical research material with relevant analytical documentation.

Our guide to batch testing and traceability explains why analytical results should remain connected to the specific sample they represent.

4. Analytical methodology

Researchers should understand which analytical techniques were used and what information those methods provide.

Read our HPLC vs LC-MS guide for a comparison of two commonly encountered analytical approaches.

5. Supporting documentation

Where batch-specific reports are available, researchers should confirm that the documentation corresponds to the relevant material.

Our peptide Certificate of Analysis guide explains how this documentation can be interpreted.

How can Semax research material be evaluated?

Peptide analysis can involve multiple analytical techniques because different methods answer different questions.

High-Performance Liquid Chromatography

HPLC separates detectable components within a sample under defined analytical conditions.

Chromatographic analysis can provide information relevant to the relative presence of the target material and other detectable components.

Researchers can learn more about chromatographic interpretation in our guide to reading an HPLC peptide report.

Mass spectrometry

Mass spectrometry provides information relating to the mass-to-charge characteristics of detected molecules.

This can provide evidence relevant to molecular identity when analytical observations are compared with the expected characteristics of Semax.

Purity and molecular identity

A reported chromatographic purity percentage and evidence relating to molecular identity answer different analytical questions.

Researchers should therefore consider the method used, expected molecular identity, batch information and scope of the analytical report together.

For a deeper explanation, read our guide to what peptide purity actually means.

BioTide UK Semax analytical data

BioTide UK currently has analytical documentation available for a tested Semax batch.

The available report records 99.29% chromatographic purity by HPLC for that tested batch.

This result relates to the specific sample and batch represented by the analytical report and should not automatically be treated as a universal value for every Semax batch.

Researchers should review the underlying documentation for the complete analytical context through the BioTide UK analytical reports library.

Why batch traceability matters

Analytical results describe the sample that was actually analysed.

Useful laboratory records can therefore include:

  • Exact compound name
  • Supplier
  • Batch or lot identifier
  • Quantity
  • Date received
  • Analytical documentation
  • Relevant storage information

Maintaining these connections supports clearer experimental documentation and helps prevent one batch's analytical result from being incorrectly attributed to another.

Lyophilised Semax research material

Peptide research materials may be supplied in lyophilised, or freeze-dried, form where specified.

Lyophilisation reduces water content through a controlled freeze-drying process and can support the stability characteristics of suitable research materials.

The term itself does not establish chromatographic purity, molecular identity or long-term stability.

Researchers can learn more in our guide to lyophilised research peptides.

Storage considerations

Storage requirements depend on the particular peptide, formulation, packaging and applicable product documentation.

Researchers should therefore follow the storage information supplied for the specific Semax material rather than assuming that every research peptide requires identical conditions.

Our guide to storing lyophilised research peptides covers the main laboratory considerations.

BioTide UK Semax research material

BioTide UK currently lists Semax 10mg within its laboratory research catalogue.

Current product information is available through the BioTide UK Semax 10mg research peptide page.

The wider selection of research materials can be viewed through the BioTide UK research peptide catalogue.

Frequently asked questions

What is Semax?

Semax is a synthetic seven-amino-acid peptide developed from research involving an ACTH-related peptide fragment.

How many amino acids are in Semax?

Semax contains seven amino-acid residues and is therefore classified as a heptapeptide.

Is Semax the same as ACTH?

No. Semax contains an ACTH-related sequence but is a distinct synthetic peptide with its own molecular identity.

Is Semax the same as Selank?

No. Semax and Selank are different seven-amino-acid peptides with distinct sequences. Read our Selank research overview for more information.

Why is Semax researched?

Semax has appeared in experimental research involving neuronal signalling, neurotrophic-factor-related pathways, gene expression and peptide biology.

What purity was reported for the tested BioTide UK Semax batch?

The analytical report currently available for the tested BioTide UK Semax batch records 99.29% chromatographic purity by HPLC. Researchers should review the corresponding report for the complete analytical context.

Does 99.29% HPLC purity confirm Semax identity?

Not by itself. Chromatographic purity and molecular identity are separate analytical questions and should be evaluated using the complete analytical documentation.

Why does the Semax batch number matter?

A batch or lot identifier helps connect the physical research material with the analytical report relating to the tested sample.

Where can researchers find BioTide UK's Semax?

Current product information is available on the BioTide UK Semax 10mg research peptide page.

Final thoughts

Semax is a synthetic heptapeptide whose ACTH-derived structure has made it an interesting compound within peptide and neuronal-signalling research.

Its relationship to ACTH and research overlap with compounds such as Selank also demonstrate why exact peptide identity matters: structurally or experimentally related peptides remain distinct molecules.

Researchers should consider molecular identity, analytical methodology and batch traceability when evaluating Semax research materials.

Continue with our Selank research overview, peptide purity guide, or batch-testing guide.

You can also view BioTide UK Semax 10mg, browse the research peptide catalogue, or review available analytical reports.

SCIENTIFIC REFERENCES

Sources & further reading

Selected peer-reviewed literature relevant to Semax, its peptide structure, neurotrophin signalling and experimental investigation in neuronal research models.

01 · PEPTIDE STRUCTURE
Tabbì et al. — Semax, an ACTH4-10 peptide analog with high affinity for copper(II) ion ↗

Research describing the Semax heptapeptide sequence and examining its biochemical interactions and properties in experimental systems.

02 · BDNF & TRKB
Dolotov et al. — Semax regulates BDNF and trkB expression in the rat hippocampus ↗

Experimental research examining changes in brain-derived neurotrophic factor and TrkB expression following Semax exposure in an animal model.

03 · NEUROTROPHIN EXPRESSION
Semax and Pro-Gly-Pro activate transcription of neurotrophins and their receptor genes after cerebral ischemia ↗

Preclinical research investigating Semax-associated changes in neurotrophin and neurotrophin-receptor gene transcription.

Learn more about how BioTide UK develops and maintains educational content: BioTide UK Research Team →

CONTINUE RESEARCHING

Related BioTide UK resources

Continue through related research materials, analytical documentation and laboratory resources.

Semax research material →View analytical reports →Explore the research range →
BIOTIDE UK
BIOTIDE UK

Research backed by verification.

Explore our research catalogue and available batch-specific analytical reports.